Summary
The investigation of in vitro platelet functions from patients with SLE and rheumatoid arthritis (RA) revealed a distinctly reduced aggregation mass after both collagen und ADP induction. The platelet serotonin contents were significantly decreased in both groups. An “aspirin-like” platelet defect could be excluded by finding a normal malonyldialdehyde release of patients' platelets upon thrombin stimulation. Significantly increased platelet associated IgG was also detected, whereas platelet associated IgM remained within normal limits. These results are interpreted as indicating an ongoing platelet release reaction induced by IgG platelet antibodies, which induce the observed impairment of platelet functions and may also lead to the release of proinflammatory platelet mediators.
Similar content being viewed by others
Abbreviations
- ACD:
-
ACD-Lösung nach USP-Formel A (Dextrose 2,45 ng; Natriumcitrat 2,2 g; Zitronensäure 0,8 g; Aqua bidest ad 100,0)
- ADP:
-
Adenosindiphosphat
- ATP:
-
Adenosintriphosphat
- Β-TG:
-
Β-Thromboglobulin
- cP:
-
chronische Polyarthritis (rheumatoid arthritis)
- ELISA:
-
enzyme-linked immunosorbent assay
- MDA:
-
Malonyldialdehyd
- PRP:
-
platelet rich plasma (thrombozytenreiches Plasma)
- PPP:
-
platelet poor plasma (thrombozytenarmes Plasma)
- SLE:
-
systemischer Lupus erythematodes
- TAIgA:
-
Thrombozyten-assoziiertes IgA
- TAIgE:
-
Thrombozyten-assoziiertes IgE
- TAIgG:
-
Thrombozyten-assoziiertes IgG
- TAIgM:
-
Thrombozyten-assoziiertes IgM
- Thr:
-
Thrombozyten
Literatur
Born GVR (1962) Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature 194:927–929
Burch RM, Knapp DR, Halushka PV (1979) Vasopressin stimulates thromboxane synthesis in the total urinary bladder effects of imidazole. J Pharmacol Exp Ther 210:334–348
Dorsch A, Meyerhoff J (1979) Mechanisms of abnormal platelet aggregation in systemic lupus erythematosus. Arthritis Rheum 22:966–974
Dorsch A, Meyerhoff J (1980) Elevated plasmaΒ-thromboglobulin levels in systemic lupus erythematosus. Thromb Res 20:617–622
Dray F, Charbonnel B, Maclouf J (1975) Radioimmunoassay of prostaglandins F2, E1, and E2 in human plasma. Eur J Clin Invest 5:311–318
Drummond AH, Gordon JL (1974) Rapid, sensitive method for platelet 5-HT. Thromb Haemost 31:366–367
Falke S, Avenarius HJ, Deicher H (1990) Beeinflussung der Aggregation normaler Spenderthrombozyten durch Plasmen und IgG von Patienten mit systemischem Lupus erythemtodes und chronischer Polyarthritis. Z Rheumatol (im Druck)
Hamberg M, Svensson J, Samuelson B (1974) Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides. Proc Natl Acad Sci USA 72:2994–2998
Holmsen H (1977) Prostaglandin endoperoxide-thromboxane synthesis and dense granule secretion as positive feed-back loops in the propagation of platelet responses during “The basic platelet reaction”. Thromb Haemost 37:109–140
Karpatkin S, Lackner HL (1975) Association of antiplatelet antibody with functional platelet disorders. Am J Med 59:599–605
Landsbury J (1958) Report of a three-year study on the systemic and articular indexes in rheumatoid arthritis. Arthritis Rheum 1:505–522
LoBuglio AF, Wayne SW, Vincour L (1983) Immune thrombocytopenic purpura — use of a125I-labeled antihuman IgG monoclonal antibody top quantify platelet-bound IgG. N Engl J Med 309:459–463
Mark H, Ginsberg H, O'Malley M (1977) Serum factors releasing serotonin from normal platelets: relation to the manifestation of systemic lupus erythematosus. Ann Intern Med 87:564–567
Meyerhoff J, Dorsch C (1981) Decreased platelet serotonin levels in systemic lupus erythematosus. Arthritis Rheum 24:1495–1501
Morris HG, Sherman NA, Shepperdsen FT (1981) Variables associated with radioimmunoassay of prostaglandin on plasma. Prostaglandins 21:770–788
Moulds RFW, Iwanov V, Young MJ (1984) Vasoactive effects of platelet aggregates. N Engl J Med 311:198–199
Mueller-Eckhardt Ch, Kayser W, Mersch-Baumert K (1980) The clinical significance of platelet-associated IgG. A study on 298 patients with various disorders. Br J Haematol 46:123–131
Murphy S (1983) In search of a platelet Coombs test. N Engl J Med 309:490–491
Mustard JK, Packham MA, Kinglough-Rathbone RL (1979) Exposure of platelet fibrinogen receptors byγ ADP and epinephrine. J Clin Invest 64:1393–1401
Parbtani A, Cameron JS (1975) Platelet and plasma serotonin concentration in glomerulonephritis. Thromb Res 15:109–125
Pfueller SL, Cosgrove L, Firkin BG, Tew D (1981) Relationship of raised platelet IgG in thrombocytopenia to platelet protein content. Br J Haematol 49:293–302
Regan MC, Lackner H, Karpatikin S (1974) Platelet function and coagulation profile in lupus erythematosus, studies in 50 patients. Ann Intern Med 81:462–468
Samuelson B, Hamberg M, Malmsten C, Svensson J (1982) The role of prostaglandin endoperoxides and thromboxanes in platelet aggregation. In: B. Samuelson, R. Paoletti (eds) Advances in Prostaglandin and Thromboxane Research 2, New York pp 737–746
Stuart MJ, Murphy S, Oski FA (1975) A simple nonradioisotope technic for the determination of detection of platelet liespan. N Engl J Med 292:1310–1317
Stuart MJ (1979) Platelet malondialdehyde formation: An indicator of platelet hyperfunction. Thromb Haemost 41:649–654
Voss Hv, Göbel U, Bermann F (1979) Methodical investigations for determination of malonyldialdehyde-production by platelets. Blut 38:86
Voss Hv, Richter O, Göbel U (1980) Methodische Untersuchungen zur Plättchenfaktor-3-Verfügbarkeit und Malonyldialdehydproduktion von Thrombozyten. In: Voss Hv, Göbel U (Hrsg) Praktische Anwendung der Thrombozytenfunktionsdiagnostik. Georg Thieme, Stuttgart, S 33–41
Wei\barth E, Baruth B, Mielke H, Limann W, Deicher H (1982) Platelets as target cells in rheumatoid arthritis and systemic lupus erythematosus: A platelet specific immunoglobulin inducing the release reaction. Rheumatol Int 2:67–73
Weiss HJ, Aledort LM (1967) Impaired platelet/connective tissue in man after aspirin ingestion. Lancet II:495–497
Weiss HJ, Lages BA (1981) Platelet malondialdehyd production and aggregation response induced by arachidonate, prostaglandin G2, collagen, and epinephrine in 12 patients with storage pool deficiency. Blood 58:27–33
Weiss HJ, Witte LD, Kaplan KL, Lages BA, Chernon A, Nossel HLB, Goddman DS, Baumgartner HR (1979) Heterogeneity in storage pool deficiency: Studies on granulebound substances in 18 patients includient various deficient inα-granules, platelet factor 4,Β-thromboglobulin, and platelet derived growth factor. Blood 54:1296–1319
Weiss HJ, Rosove MH, Lages BA, Kaplan KL (1980) Acquired storage pool deficiency with increased platelet-associated IgG. Am J Med 69:711–717
Zahavi J, Marder VJ (1974) Acquired ‘storage pool disease’ of platelets associated with circulating antiplatelet antibodies. Am J Med 56:883–890
Zeller J, Wei\barth E, Baruth B, Mielke H, Deicher H (1983) Serotonin content of platelets in inflammatory rheumatic diseases. Arthritis Rheum 6:532–540
Author information
Authors and Affiliations
Additional information
Mit Unterstützung der Deutschen Forschungsgemeinschaft, SFB 54-G3
Rights and permissions
About this article
Cite this article
Horn, A., Avenarius, H.J. & Deicher, H. Thrombozytenfunktion und Thrombozyten-assoziierte Immunglobuline bei Patienten mit systemischem Lupus erythematodes und chronischer Polyarthritis. Klin Wochenschr 68, 460–465 (1990). https://doi.org/10.1007/BF01648899
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01648899